openPR Logo
Press release

OTC Drug And Dietary Supplement* Market: Surging Growth, Key Trends, and Major Players

01-27-2025 12:05 PM CET | Health & Medicine

Press release from: The Business Research Company

OTC Drug And Dietary Supplement* Market Share

OTC Drug And Dietary Supplement* Market Share

Projected to reach $470.7 billion by 2029, the OTC drug and dietary supplement* market is on a robust trajectory, propelled by increasing fitness enthusiasts, demographic shifts, aging population, stringent regulatory standards, and innovative marketing strategies.

What Is The Projected Market Size Of The Global OTC Drug And dietary supplement* Market And Its Growth Rate?
• The OTC drug and dietary supplement* market size was $332.52 billion in 2024 and is expected to reach $355.94 billion in 2025, with a CAGR of 7.0%.
• Growth during this period can be attributed to the increasing number of fitness enthusiasts, demographic shifts and aging population, regulatory approvals and safety standards, pharmacy and retail expansions, and effective marketing and advertising strategies.
• The market is projected to further grow to $470.7 billion in 2029 at a CAGR of 7.2%.
• Trends such as personalized nutrition and supplements, nutraceutical innovations, expansion of functional foods, global health crises preparedness, and government wellness initiatives are expected to drive this growth.

What Is Driving The Growth In The OTC Drug And dietary supplement* Market?
The growth of the OTC drug and dietary supplement* market is being propelled by the rise in pharma R&D expenditure. Investment in R&D enables companies to develop, design, and enhance their offerings, driving innovation and productivity in the design and formulation of OTC, and dietary supplements. For instance, Eurostat reported a 6.34% increase from €331 billion ($361.48) to €352 billion ($384.42 billion) in the EU's research and development expenditure in 2022.

Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=12096&type=smp

Who Are the Key Players Driving OTC Drug And dietary supplement* Market Growth?
• Pfizer Inc.
• Johnson & Johnson Ltd.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A
• Abbott Laboratories Inc
• GSK plc
• Gilead Sciences Inc.
• Reckitt Benckiser Plc.
• Teva Pharmaceutical Industries Ltd.
• Alcon Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Church & Dwight* Co Inc
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Glenmark Pharmaceuticals Limited
• Alkem Laboratories Ltd
• Nutraceutical International Corporation
• Procter & Gamble Health Limited
• Reese Pharmaceutical Company
• UPM Pharmaceuticals Inc
• Gemini Pharmaceuticals Inc.
• Pharmavite LLC
• Now Health Group Inc.
• Alfresa Pharma Corporation

What Are The Key Trends In The OTC Drug And dietary supplement* Market?
• Product innovations
• Clean label and natural ingredients
• cannabidiol* and hemp-based products
• Sustainable and eco-friendly packaging
• Partnerships and collaborations

What Are The Segments Of The Global OTC Drug And dietary supplement* Market?
• By Category: Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other Categories
• By Dosage Form: Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms
• By Application: Pharmacies, Grocery Stores, Vitamin And Health Food Stores, Online Pharmacies

Which Region Leads The OTC Drug And dietary supplement* Market?
North America is the dominant region in the global OTC drug and dietary supplement* market. The regions analyzed in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/otc-drug-and-dietary-supplement-global-market-report

What Is Covered In The OTC Drug And dietary supplement* Market Global Market Report?
- Market Size Analysis: Analyze the OTC Drug And dietary supplement* Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the OTC Drug And dietary supplement* Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall OTC Drug And dietary supplement* Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the OTC Drug And dietary supplement* Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report: https://www.thebusinessresearchcompany.com/customise?id=12096&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Drug And Dietary Supplement* Market: Surging Growth, Key Trends, and Major Players here

News-ID: 3834486 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to